Randomized Phase II/III Trial of Consolidation Radiation + Immunotherapy for ES-SCLC RAPTOR TRIAL
Protocol: NRG – LU007 SCHEMA NRG-LU007 Please Note: Below is partial eligibility, for full eligibility requirement’s, please contact GHCI Research Department at (810) 762-8181, (810) 762-8079 and/or (810) 762-8038. Thank you! Eligibility: Pathologically proven diagnosis of extensive stage small cell lung cancer. Partial response (PR) or stable disease (SD) after 4-6 cycles of etoposide/platinum (E/P) […]